Loading…

Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration

A series of 5β-methylprolyl-2-cyanopyrrolidine analogs were synthesized and identified as long-acting DPP-IV inhibitors. The mode of binding and the effect on the plasma glucose level were evaluated. A series of 5β-methylprolyl-2-cyanopyrrolidine analogs were synthesized and evaluated as DPP-IV inhi...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2007-04, Vol.15 (7), p.2631-2650
Main Authors: Kondo, Takashi, Nekado, Takahiro, Sugimoto, Isamu, Ochi, Kenya, Takai, Shigeyuki, Kinoshita, Atsushi, Tajima, Yohei, Yamamoto, Susumu, Kawabata, Kazuhito, Nakai, Hisao, Toda, Masaaki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of 5β-methylprolyl-2-cyanopyrrolidine analogs were synthesized and identified as long-acting DPP-IV inhibitors. The mode of binding and the effect on the plasma glucose level were evaluated. A series of 5β-methylprolyl-2-cyanopyrrolidine analogs were synthesized and evaluated as DPP-IV inhibitors, and the duration of their ex vivo activity was assessed. Comparison of their potency and duration of action was done among three different species. The mode of binding was investigated, and the effect on the plasma glucose level was evaluated. Structure–activity relationships are also presented.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2007.01.041